Nasdaq Biotechnology Ishares ETF (IBB)

$128.36 0.67 (0.52%)

11:26 EDT IBB Stock Quote Delayed 30 Minutes

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector

By Josh Enomoto, InvestorPlace Contributor Mar 15, 2023

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market

The 7 Best Biotech Stocks to Buy

The 5 Best ETFs to Buy for March 2022

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 497,178

Day's Range $128.07 - $129.20

52-Week Range $104.29 - $138.74

Dividend & Yield N/A (N/A)

IBB Stock Predictions, Articles, and Nasdaq Biotechnology Ishares ETF News

From InvestorPlace
From the Web

7 Best ETFs to Buy to Cover a Broad Spectrum of Opportunities

By Josh Enomoto, InvestorPlace Contributor Aug 27, 2021

With so many stocks to choose from, trying to find the right ones can be a brutal task, which is why ETFs are so convenient.

4 Top Stock Trades for Wednesday: AAPL, TGT, RIDE, IBB

By Bret Kenwell, InvestorPlace Contributor Jun 15, 2021

Apple, Target, Lordstown Motors and the iShares Nasdaq Biotechnology ETF (IBB) were our top stock trades for Wednesday.

7 Health-Focused ETFs To Buy Now For the Post-Covid Future

By Tezcan Gecgil, InvestorPlace Contributor Apr 29, 2021

The healthcare sector outperformed in the past year due to the pandemic. Here are seven ETFs for your portfolio to look beyond Covid-19.

3 Biotech Stocks to Buy As Things Heat Up for the Sector

By Tyler Craig, Tales of a Technician Feb 18, 2021

Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high. Here's how to play it.

Which Biotech Stocks Are a Buy on Earnings?

By Louis Navellier, Editor, Growth Investor Nov 3, 2020

If you’re interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip.

3 Biotech Stocks to Buy Right Now

By Chris Tyler, InvestorPlace Contributor Oct 16, 2020

Regardless of lockdowns or otherwise, these biotech stocks are positioned to rally strongly in the weeks and months ahead

4 Biotech Stocks to Buy for Big Gains in 2020

By Tezcan Gecgil, InvestorPlace Contributor Sep 18, 2020

The novel coronavirus is weighing on the market, but these four biotech stocks can survive. Here's what you need to know to profit now.

A New Healthcare Stock Pick in the Industry of the Decade

By InvestorPlace Research Staff Sep 3, 2020

This company is riding a powerful trend in the future of healthcare. Plus, it offers high growth, a huge potential market and a path to profitability.

The 5 Best Tech ETFs to Buy for Safer Growth

By Tezcan Gecgil, InvestorPlace Contributor Aug 25, 2020

Here are five tech ETFs to buy if you believe that global technology stocks will continue to enjoy their solid runs in the coming quarters.

3 Biotech Stock ETFs to Buy For Further Upside In 2021

By Nicolas Chahine, InvestorPlace Contributor Aug 17, 2020

Biotech stocks are winners this year, but there's still room to buy in for profit taking. ETFs such as IBB, XBI and XLV will continue to win.

Biotech Stocks Have Been on Fire, But Timing Is Everything

By Nicolas Chahine, InvestorPlace Contributor May 27, 2020

Consensus is that the experts will find a vaccine to Covid-19 soon, so the biotech stocks have rallied hard. Buying them now carries risk.

Biotech Stocks: Coronavirus Response Shows How Far We’ve Come …

By InvestorPlace Research Staff Mar 9, 2020

Look for biotech stocks as a group to gain more than 20% this year … with the best, most innovative firms more than doubling.

3 Healthcare Stocks to Buy This Year

By Nicolas Chahine, InvestorPlace Contributor Feb 24, 2020

The buyers are in charge of the healthcare stocks this year. And judging from their charts, these stocks and ETFs in particular offer great opportunities.

First-Mover Advantage Will Benefit Amarin Stock More Than You Think

By Ian Cooper, InvestorPlace Contributor Feb 24, 2020

There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.

The Top Performing Sector in 2020 Will Be …

By InvestorPlace Research Staff Feb 19, 2020

The future of healthcare will really start to take shape this year, and the next decade will bring advancements that we can only imagine in our wildest dreams.

3 Top Drug Stocks to Own In 2020

By Ian Cooper, InvestorPlace Contributor Jan 3, 2020

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.

3 of the Best Biotech ETFs on the Market

By Todd Shriber, InvestorPlace Contributor Jan 2, 2020

The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.